Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FORWARD: Functional Outcomes in Real-World Treatment And Revascularization of Non-dominant and Distal M2 Occlusions

NCT07749170 is registered in ClinicalTrials.gov with Penumbra Inc. as lead sponsor.

NCT NCT07749170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07749170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FORWARD: Functional Outcomes in Real-World Treatment And Revascularization of Non-dominant and Distal M2 Occlusions
Lead sponsor
Penumbra Inc.
Phase
Observational
Overall status
Recruiting
Start date
June 26, 2026
Completion date
September 30, 2028
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke, acute ischemic stroke (ais) related to a distal occlusion